Women with polycystic ovary syndrome exhibit an increased risk of left ventricular hypertrophy

被引:0
|
作者
De Jong, K. A. [1 ]
Appelbe, A. [1 ]
Cukier, K. [1 ]
Kotowicz, M. [1 ]
McGee, S. L. [1 ]
机构
[1] Deakin Univ, Metab Res Unit, Geelong, Vic, Australia
关键词
D O I
10.1016/j.yjmcc.2018.05.117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
103
引用
收藏
页码:38 / 39
页数:3
相关论文
共 50 条
  • [31] Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome
    Bednarska, Sylwia
    Fryczak, Jolanta
    Siejka, Agnieszka
    CYTOKINE, 2020, 134
  • [32] Increased serum neopterin levels in women with polycystic ovary syndrome
    Barutcuoglu, Burcu
    Bozdemir, A. Erkin
    Dereli, Didem
    Parildar, Zuhal
    Mutaf, M. Isil
    Ozmen, Dilek
    Bayindir, Oya
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (03): : 267 - 272
  • [33] Increased plasma visfatin concentrations in women with polycystic ovary syndrome
    Chan, Te-Fu
    Chen, Yi-Ling
    Chen, Hung-Hseng
    Lee, Chien-Hung
    Jong, Shiang-Bin
    Tsai, Eing-Mei
    FERTILITY AND STERILITY, 2007, 88 (02) : 401 - 405
  • [34] Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
    Carmina, Enrico
    Lobo, Roger A.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (11) : 1385 - 1388
  • [35] WOMEN WITH POLYCYSTIC OVARY SYNDROME AND RISK OF CARDIOVASCULAR DISEASE
    Blagojevic, Iva Perovic
    Eror, Tatjana
    Pelivanovic, Jovana
    Jelic, Svetlana
    Kotur-Stevuljevic, Jelena
    Ignjatovic, Svetlana
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2017, 36 (03) : 259 - 269
  • [36] Cardiovascular disease risk in women with polycystic ovary syndrome
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (1): : 7 - 7
  • [37] Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Paterakis, Thomas S.
    Diamanti-Kandarakis, Evanthia
    CURRENT OBESITY REPORTS, 2014, 3 (04): : 377 - 386
  • [38] Carcinoma risk in women with polycystic ovary syndrome (PCOS)
    Weiss, JM
    Ortmann, O
    GYNAKOLOGE, 2002, 35 (01): : 31 - 35
  • [39] Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
    Armeni, Eleni
    Lambrinoudaki, Irene
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 579 - 590
  • [40] Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Thomas S. Paterakis
    Evanthia Diamanti-Kandarakis
    Current Obesity Reports, 2014, 3 (4) : 377 - 386